These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Paroxetine (paxil): use in clinical practice]. Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199 [No Abstract] [Full Text] [Related]
3. Spotlight on paroxetine in psychiatric disorders in adults. Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788 [TBL] [Abstract][Full Text] [Related]
4. Substance-P antagonists: a new treatment for depression? Nutt D Lancet; 1998 Nov; 352(9141):1644-6. PubMed ID: 9853433 [No Abstract] [Full Text] [Related]
5. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review. Bourin M Hum Psychopharmacol; 2003 Apr; 18(3):185-90. PubMed ID: 12672169 [TBL] [Abstract][Full Text] [Related]
6. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880 [TBL] [Abstract][Full Text] [Related]
7. Paroxetine and its uses in psychiatry. Bell C; Nutt D Hosp Med; 1999 May; 60(5):353-6. PubMed ID: 10396411 [TBL] [Abstract][Full Text] [Related]
8. Successful paroxetine treatment of major depression in an adult form of metachromatic leukodystrophy with cognitive disturbances. Vella G; Loriedo C; Raccah R; Baldassarre P; Paolillo A Can J Psychiatry; 1998 Sep; 43(7):748-9. PubMed ID: 9773228 [No Abstract] [Full Text] [Related]
9. Paroxetine in the treatment of generalised anxiety disorder. Snyderman SH; Rynn MA; Bellew K; Rickels K Expert Opin Pharmacother; 2004 Aug; 5(8):1799-806. PubMed ID: 15264994 [TBL] [Abstract][Full Text] [Related]
11. Paroxetine: a review. Bourin M; Chue P; Guillon Y CNS Drug Rev; 2001; 7(1):25-47. PubMed ID: 11420571 [TBL] [Abstract][Full Text] [Related]
12. [Depression and anxiety. Broad spectrum SSRI to control both]. MMW Fortschr Med; 2001 Sep; 143(35-36):55-6. PubMed ID: 11584534 [No Abstract] [Full Text] [Related]
13. Clinical practice guidelines for depression in young people. Jureidini JN; Tonkin AL Med J Aust; 2003 Mar; 178(6):300; author reply 300-2. PubMed ID: 12633493 [No Abstract] [Full Text] [Related]
14. Paroxetine treatment of trichotillomania in an adolescent. Block C; West SA; Baharoglu B J Child Adolesc Psychopharmacol; 1998; 8(1):69-71. PubMed ID: 9639081 [TBL] [Abstract][Full Text] [Related]
15. Depressing misrepresentation? Newton J; Langlands A Lancet; 2004 May; 363(9422):1732. PubMed ID: 15158640 [No Abstract] [Full Text] [Related]
16. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control. Rosenthal M J Clin Psychiatry; 2003 Oct; 64(10):1245-9. PubMed ID: 14658975 [TBL] [Abstract][Full Text] [Related]
17. The paroxetine controversy: lessons for ketamine trials. Zhang MW; Ho RC Lancet Psychiatry; 2015 Dec; 2(12):1057-8. PubMed ID: 26613847 [No Abstract] [Full Text] [Related]
18. Withdrawal syndromes after paroxetine and sertraline discontinuation. Fava GA; Grandi S J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071 [No Abstract] [Full Text] [Related]
19. Focus on paroxetine. Green B Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775 [TBL] [Abstract][Full Text] [Related]
20. High venlafaxine serum levels after prior fluoxetine medication. Gerbaulet M; Engel A; Hiemke C; Dahmen N J Clin Psychopharmacol; 2012 Apr; 32(2):295-7. PubMed ID: 22388163 [No Abstract] [Full Text] [Related] [Next] [New Search]